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food frequency questionnaire and shopping and budgeting questionnaire.
Associations between consideration of nutritional value and nutrition label
use with vegetable, wholegrain, legume, snack food and soft drink intake
were evaluated using linear regression, adjusting for age, gender and
education.
Results: In adjusted models, more consideration of the nutrition value of
foods was positively associated with vegetable intake (b¼ 0.188; p¼ 0.025),
wholegrain intake (b¼ 0.213;p¼ 0.015) andnegativelyassociatedwith snack
food intake (b¼ -0.236, p¼ 0.006). More frequent reading of nutrition labels
was positively associated with legume intake (b ¼ 0.185; p ¼ 0.036). Better
understanding of nutrition labels was positively associated with vegetable
intake (b ¼ 0.780; p ¼ 0.035), wholegrain intake (b ¼ 0.233; p ¼ 0.008), and
legume intake (b ¼ 0.254; p ¼ 0.004). There were no associations between
soft drink intake and nutrition value consideration or nutrition label use.
Conclusions: These ﬁndings suggest that increasing consideration of the
nutrition value of foods and nutrition label use may support healthy eating
in adults with depression.
Funding source(s): NHMRC.
CONCURRENT SESSION 5: FOOD COMPONENTS.
CD63 UPREGULATION ON BASOPHILS IS NOT A PREDICTOR OF
SALICYLATE SENSITIVITY
S. Malakar, P. Gibson, J. Muir. Department of Gastroenterology, Central
Clinical School, Monash University, VIC, Australia
E-mail address: sreepurna.malakar@monash.edu (S. Malakar)
Background/Aims: About 2.5% of the general population show pseu-
doallergic reactions to salicylates (including aspirin). Patients with aspirin-
exacerbated respiratory disease (AERD) show symptomatic improvement
on low salicylate diet. Aspirin sensitivity is detected through oral provoca-
tion test - contraindicated in anaphylactoid reaction. Food salicylate sensi-
tivity is detected through highly restrictive and lengthy ‘elimination and
rechallenge diet’ raising compliance issues. More recently, an in vitro assay,
the basophil activation test (BAT), is reported to detect pseudoallergic re-
actions with high sensitivity and speciﬁcity. However, the results remain
controversial. The aim of this study was to examine the ability of BAT to
differentiate known salicylate sensitivity from healthy controls (HC).
Methods: Peripheral blood of 10 AERD patients (2 males, 8 females), 10 HC
(3 males, 7 females) was stimulated in vitro with aspirin (5, 2.5, 1.25, 0.6,
0.3, 0.15, 0.07 mg/ml). Flow cytometry was used to detect activated ba-
sophils (IgE+/CD63+). Stimulation index (SI) and percentage activation (%
act) were used to determine basophil activation. Receiver-operator char-
acteristics (ROC) were determined.
Results:Mean SI in AERD was similar to HC for all concentrations [p-values
ranged from 0.178 (0.6 mg/mL) to 0.800 (0.07 mg/mL), independent
sample t-tests)]. Likewise, % act did not differ between the groups [p-
values ranged from 0.869 (2.5 mg/mL) to 0.498 (5 mg/mL)]. No cut-off
values were able to discriminate the two subject groups (area-under-the-
curve for ROC analyses < 0.5 for all).
Conclusions: BAT using CD63 is unable to predict salicylate sensitivity. It
may not be a useful diagnostic test for non-IgE mediated pseudoallergic
reactions.
Funding source(s): Gastroenterology Department.BITTER TASTE PHENOTYPE AND TAS2R38 A49P GENOTYPE INFLUENCE
ALCOHOL CONSUMPTION IN MALES BUT NOT FEMALES
E.L. Beckett 1,2, K. Duesing 2, L. Boyd 1, X. Ng 1, Z. Yates 3, M. Veysey 4, M.
Lucock 1. 1 Environmental & Life Sciences, University of Newcastle, NSW,
Australia; 2 Food & Nutrition Flagship, CSIRO, North Ryde, NSW, Australia;
3Biomedical Science & Pharmacy, University of Newcastle, NSW, Australia;
4Central Coast Health, Gosford, NSW, Australia
E-mail address: emma.beckett@uon.edu.au (E.L. Beckett)
Background/Aims: TAS2R38 polymorphisms inﬂuence bitter taste
phenotype. Both have been linked to alcohol consumption; however thishas not been demonstrated in all cohorts tested. To date, this interaction
has been studied in small cohorts (< 100 participants) with males and
females combined, with not consideration of a potential gender dimor-
phism. Therefore we used a larger cohort to assess the gender speciﬁcity of
this relationship.
Methods: Blood was collected from patients undergoing routine colo-
noscopy (n ¼ 262). TAS2R38 genotype (A49P) was assessed using RFLP-
PCR. Bitter taste phenotype (non-tasters vs. tasters) was determined using
6-n-propylthiouracil. Alcohol consumption was assessed using food fre-
quency questionnaires. Frequencies of genotypes and phenotypes were
compared by chi-squared tests. Pairwise comparisons were made using
least squares means (adjusted for age and smoking status) and t-tests.
Results: Distribution of genotype and phenotype did not vary between
genders (c2 ¼ 6.52, p ¼ 0.16 and c2 ¼ 4.67, p ¼ 0.13, respectively).
Males were signiﬁcantly older (60.4 ± 1.0 vs. 64.4 ± 1.2, p ¼ 0.009) and
drank signiﬁcantly more alcohol (5.0 ± 0.8 vs. 21.1 ± 2.6, p ¼ 0.0001). In
males genotype and phenotype predicted alcohol intake, with carriers of
the “P” variant and “tasters” drinking less (18.1 ± 3.1 g/day vs. 31.7 ± 4.6 g/
day, p ¼ 0.01 and 19.1 ± 2.9 vs. 34.2 ± 5.6, p ¼ 0.02, respectively). No re-
lationships were found in females. A signiﬁcant interaction was found
between gender and genotype (p ¼ 0.004) and phenotype (p ¼ 0.005).
Conclusions: A gender dimorphism exists in the relationships between
TAS2R38 genotype, bitter phenotype and alcohol consumption. A signiﬁ-
cant interaction exists between gender and both genotype and phenotype
when predicting alcohol intake.
Funding source(s): CSIRO.
DOES DAILY CONSUMPTION OF PECTIN LOWER CHOLESTEROL
CONCENTRATION? A SYSTEMATIC REVIEW AND META-ANALYSIS
K.E. Mills, D. Mackerras. Food Standards Australia New Zealand, ACT,
Australia
E-mail address: dorothy.mackerras@foodstandards.gov.au (D. Mackerras)
Background/Aims: Soluble ﬁbres are thought to lower blood cholesterol
concentrations. A systematic review of the effect of pectin, a soluble ﬁbre,
on cholesterol concentrations was undertaken.
Methods: EMBASE, PubMed and Cochrane CENTRAL were searched in
December 2013. Randomised controlled trials lasting at least two weeks
investigating increased consumption of pectin added to foods or as a sup-
plement compared to a suitable control group and reporting at least total
cholesterol concentrations in non-acutely ill subjects were included. Studies
testingmixtures ofﬁbres orwhole foodswere excluded because their effects
couldnot be attributed to pectin. Studyqualitywas assessedusing theRisk of
Bias criteria; high quality studieswere double-blind and placebo-controlled.
Meta-analysis was conducted using the generic inverse variance method.
Results: Of the 115 articles retrieved, only seven met all inclusion criteria.
These tested intakes of pectin between 9 and 36 g/day. The number of
participants ranged from six to 66 and most studies were conducted in
hypercholesterolaemic people. There was a mean reduction in blood total
cholesterol concentration of 0.36 mmol/L (95% CI: -0.52 to -0.19 mmol/L, p
< 0.001) and moderate heterogeneity (I2 ¼ 45%) across all studies. Similar
magnitudes of effect were seen in the four high quality studies and in the
one, low quality, study conducted with normocholesterolaemic subjects.
Conclusions: Daily consumption of at least 9 g pectin/day (a large amount
compared to current average total ﬁbre intakes) may reduce blood total
cholesterol concentrations. Further studies are needed to conﬁrm this ef-
fect, especially in normocholesterolaemic populations.
Funding source(s): None.RELATIONSHIP BETWEEN CAFFEINE CONSUMPTION AND SLEEP IN
AUSTRALIAN CHILDREN
M. Watson 1, S. Banks 1, M. Kohler 1, A. Coates 2. 1Centre for Sleep Research,
University of South Australia, SA, Australia; 2Alliance for Research in Exercise,
Nutrition and Activity, University of South Australia, SA, Australia
E-mail address: watej001@mymail.unisa.edu.au (M. Watson)
Background/Aims: Currently Australia does not have caffeine intake
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Physical Activity Survey found that children 9-13y consumed on average
19.2 mg caffeine per day. However, little is known about caffeine con-
sumption and its impact on sleep in children. This study assessed caffeine
consumption and sleep in school aged children.
Methods: Children aged 8-12 y (10.7 ± 1.3 y, 49% male) were recruited
through South Australian schools and the community for a retrospective,
cross sectional study. Demographics, caffeine intake (a Food Frequency
Questionnaire), and daytime sleepiness (Paediatric Daytime Sleepiness
Scale) were obtained via child and parent report.
Results: Data from 230 children demonstrated daily caffeine intake
ranged between 0e64.1 mg (7.8 ± 11.7 mg). Gender did not impact
caffeine intake (p ¼ 0.97). 74% of 8 year olds consumed caffeine (8.0 ±
10.5 mg), 78% of 9 years olds (8.3 ± 9.6 mg), 72% of 10 year olds (10.1 ±
13.5 mg), 83% of 11 year olds (9.7 ± 13.4 mg) and 87% of 12 year olds
(12.6 ± 13.2 mg). Twenty-ﬁve percent (n ¼ 58) of the sample consumed
between 11.1mg (~Standard chocolate bar) and 64.1 mg (~one small
latte) of caffeine/day. Daily caffeine consumption had a signiﬁcant
relationship with age (r ¼ 0.14, p ¼ 0.03) and daytime sleepiness (r ¼
0.14, p ¼ 0.03). Children who were in the top 25% of caffeine con-
sumption had signiﬁcantly higher daytime sleepiness compared to the
remaining 75% of the sample (p ¼ 0.05).
Conclusions: These ﬁndings show that majority of children aged 8e12 y
consume caffeine. The study also shows a signiﬁcant relationship between
caffeine intake and daytime sleepiness in children, with greater caffeine
consumption associated with more daytime sleepiness.
Funding source(s): N/A.
THE METABOLISM OF DIETARY ARACHIDONIC AND EICOSAPENTAENOIC
ACIDS IN ATLANTIC SALMON AS AFFECTED BY ENVIRONMENTAL
TEMPERATURE
G. Turchini, F. Norambuena. Deakin University, VIC, Australia
E-mail address: giovanni.turchini@deakin.edu.au (G. Turchini)Background/Aims: Aquaculture is encountering sub-optimal conditions
due to changing environments. Simultaneously, shortages in marine
oils are resulting in a reduction of dietary long chain-PUFA. The effects
of water temperature and dietary arachidonic acid (ARA):EPA ratios on
the regulation of fatty acid (FA) metabolism in salmon were
investigated.
Methods: Atlantic salmon kept at optimal (10 C) and elevated (20 C)
temperature were fed one of three experimental diets. The diets had
identical FA composition with the exception of the EPA/ARA ratio,
varying from 2.4 to 0.1. The FA metabolism was assessed via the whole-
body-fatty-acid-method and selected genes expression was quantiﬁed
by qPCR.
Results: The higher temperature showed an increase in the total FA b-
oxidation (from 1,645.3 to 814.5 nmol/g/day at 20C or 10 C, respectively).
At both temperatures, the b-oxidation of SFA andMUFAwas lower in group
with highest dietary EPA supply. The higher temperature showed a
reduction in the activity and gene transcription of FA desaturases (D6fad
and D5fad) and elongase Elovl2, whereas elongase Elovl5 was not affected.
The metabolic fate of ARA was affected by temperature and dietary
treatment. Whereas, in ﬁsh held at 20 C, the metabolic fate of dietary EPA
was identical for all three treatments.
Conclusions: Temperature plays remarkable effects on EPA and ARA
metabolism. Increased dietary ARA supply, relative to EPA, is beneﬁcial in
ﬁsh held at elevated water temperatures. These ﬁndings contribute to-
wards the formulation of novel functional aquaculture diets.
Funding source(s): ARC Discovery Project.
CONCURRENT SESSION 6: LIPIDS.
ROSUVASTATIN, LYCOPENE AND OMEGA-3 FATTY ACIDS: A POTENTIAL
TREATMENT FOR SYSTEMIC INFLAMMATION IN COPD
E.J. Williams 1,2, K.J. Baines 1,2, J.M. Smart 1,2, P.G. Gibson 1,2, L.G.
Wood 1,2. 1Centre for Asthma and Respiratory Diseases, Hunter Medical
Research Institute, Newcastle, NSW, Australia; 2University of Newcastle,NSW, Australia
E-mail address: evan.j.williams@uon.edu.au (E.J. Williams)
Background/Aims: Chronic Obstructive Pulmonary Disease (COPD) is
characterized by lung and airway inﬂammation, resulting in loss of lung
function. Systemic inﬂammation is a feature of COPD contributing to many
associated co-morbidities. Statins, omega-3 fatty acids (DHA and EPA) and
lycopene have been shown to decrease systemic inﬂammation; this
combination has not been studied previously. The aim of this study was to
identify changes in systemic and airway inﬂammation induced by statins
and/or DHA, EPA and lycopene in COPD.
Methods: COPD patients (n ¼ 11) received rosuvastatin (20 mg/day) for 4
weeks, then a combination of rosuvastatin (20 mg/day), DHA and EPA (1.5
g/day) and lycomato (45 mg/day) for 8 weeks. Blood and sputum were
collected and lung function measured by spirometry at baseline, week 4
and 12. Plasma C-reactive protein (CRP) and IL-6 were measured using
ELISA; peripheral blood gene expression was measured using nCounter™
GX Human Inﬂammation Kit 2.
Results: Following interventions, clinical characteristics were unchanged.
Plasma IL-6 and CRP were unchanged by intervention, sputum neutrophils
were increased andmacrophages decreased by rosuvastatin (p¼ 0.020 and
p ¼ 0.015; respectively). Rosuvastatin increased LTB4R and decreased
CXCL10 and AGER blood gene expression. When lycopene and omega-3
fatty acids were added, LTB4R decreased and CXCL10 decreased to basal
levels, whilst combined intervention increased ALOX15 blood gene
expression.
Conclusions: This study shows rosuvastatin, omega-3 fatty acids and
lycopene may have anti-inﬂammatory effects systemically, but rosuvas-
tatin may increase airway neutrophils, which would be undesirable in
COPD, warranting further investigation.
Funding source(s): NHMRC, Centre for Clinical Research Excellence.
POLYUNSATURATED FATTY ACID FOOD FREQUENCY QUESTIONNAIRE
VALID-ATION IN PEOPLE WITH END STAGE RENAL DISEASE ON
DIALYSIS
L. Roach 1, K. Russell 2, K. Lambert 3, J. Holt 3, B. Meyer 1. 1 School of Medicine,
University of Wollongong, NSW, Australia; 2Charles Sturt University, Wagga
Wagga, NSW, Australia; 3Renal Unit, Wollongong Hospital, NSW, Australia
E-mail address: lar966@uowmail.edu.au (L. Roach)
Background/Aims: People on dialysis have a high risk of cardiovascular
disease. PUFA in particular omega-3 fatty acids are of interest in this
population due to their cardioprotective properties. The PUFA food
frequency questionnaire (FFQ) is a validated tool to measure PUFA
intake in healthy populations, but has yet to be validated in a diseased
population. The aim of this study is to validate the PUFA FFQ using the
method of triads in a population of end stage renal failure patients on
dialysis.
Methods: Participants (n ¼ 32) completed the PUFA FFQ and multiple 24
hour recalls, non-fasting blood samples were taken (n ¼ 29) for erythro-
cyte fatty acid analysis. The triangular relationship between the PUFA FFQ,
24 hour recalls and the biomarker were assessed using the method of
triads, which calculated validity coefﬁcients for PUFA. Agreement between
the two dietary methods were also assessed using Bland-Altman plots and
classiﬁcation by quintiles.
Results: The PUFA FFQ was a valid measure of all PUFA except for doco-
sapentaenoic acid (DPA) and arachidonic acid (AA). Strong validity co-
efﬁcients were found for long chain omega-3 fatty acids eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) of 0.914 (95% CI: 0.665, 0.997)
and 0.889 (95% CI: 0.706, 0.994) respectively. Bland Altman plots showed a
good level of agreement between the PUFA FFQ and the 24 hour recalls as
approximately 95% of observations were between the levels of agreement.
Conclusions: The PUFA FFQ is a valid tool for assessing PUFA intake in a
population of dialysis patients.
Funding source(s): N/A.
FAT TYPE IN PHYTOSTEROL SPREADS INFLUENCE THEIR CHOLESTEROL-
LOWERING POTENTIAL: A SYSTEMATIC REVIEW AND META-ANALYSIS
OF RCTS
